Jean Holewinski, DPM
Podiatrist · Aventura, FLNPI 1962594283
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (36.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Biotissue Holdings Inc. accounts for 66.5% of it on its own, with 43 other manufacturers making up the rest. Reporting peaked in 2023 at $13,974 and has fallen 91.4% since, to $1,200 in 2025. Among podiatrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $156.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$23K
- Arthrex$4K
- Stryker$2K
- Paragon 28, Inc.$693
- Polynovo North America LLC$677
- Southern Edge Orthopaedics, Inc.$537
- plus $4K from 38 others
What the payments were for
- Consulting fees$12,85037%
- Speaking & faculty fees$7,50021%
- Travel & lodging$1,9085%
- Food & beverage$9,69128%
- Education$3,0619%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEOX$6,727
- CLARIX$4,522
- Product Portfolio$693
- PRIME SERIES$664
- Kerecis Omega3 Marigen$564
- Kerecis Omega3 SurgiClose$438
- Prokera$387
- AmnioGraft$387
- AmnioGuard$387
- Novosorb BTM$265
- INFINITY$174
- Proclaim IPG$172
- PROPHECY$140
- KRYSTEXXA$135
- Apligraf$125
- PROstep$124
- PROCLAIM$123
- Versajet$113
- Kerecis Omega3 GraftGuide$108
- PROSTEP MICA$104
How this compares
$35,011 in reported general payments places this provider in the 95th percentile of 588 podiatrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 80 | $620 |
| Ciclopirox | 13 | $487 |
| Ketoconazole | 42 | $485 |
| Meloxicam | 22 | $79 |
| Methylprednisolone | 12 | $51 |
| Ibuprofen | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Aventura
- Marie WilliamsAventura$96K
- James CottomSarasota$1.8M
- Caroline KiserFleming Island$206K
- Adam PerlerLargo$160K
- Desmond BellJacksonville$125K
- Jeffrey KarrLakeland$101K
- Todd BrennanTampa$88K
- Robert HooverLake Mary$71K
- Daniel BrandweinPompano Beach$70K
- John TorregrosaMiami$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.